General Information of the Compound
| Compound ID |
CP0408806
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[3-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,37S,40S,43R,46S)-43-benzyl-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1S)-1-hydroxyethyl]-22-(hydroxymethyl)-46-(1H-imidazol-5-ylmethyl)-37-(1H-indol-3-ylmethyl)-25,41-dimethyl-3,6,12,18,21,24,27,30,33,36,39,42,45,48-tetradecaoxo-50,51-dithia-2,5,11,17,20,23,26,29,32,35,38,41,44,47-tetradecazatetracyclo[29.17.4.07,11.013,17]dopentacontan-40-yl]propyl]guanidine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C77H113N23O16S2
|
||||||||||||||||||
| Molecular Weight |
1681.03
|
||||||||||||||||||
| Canonical SMILES |
CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N(C)[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2)[C@H](C)O)[C@@H](C)CC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C77H113N23O16S2/c1-8-40(3)59-71(112)94-54-37-117-118-38-55(68(109)97-61(43(6)102)72(113)87-42(5)62(103)92-53(36-101)66(107)96-60(41(4)9-2)75(116)100-30-18-26-58(100)74(115)99-29-17-25-57(99)70(111)95-59)93-63(104)49(23-15-27-83-76(78)79)88-64(105)50(32-45-34-85-48-22-14-13-21-47(45)48)90-69(110)56(24-16-28-84-77(80)81)98(7)73(114)52(31-44-19-11-10-12-20-44)91-65(106)51(89-67(54)108)33-46-35-82-39-86-46/h10-14,19-22,34-35,39-43,49-61,85,101-102H,8-9,15-18,23-33,36-38H2,1-7H3,(H,82,86)(H,87,113)(H,88,105)(H,89,108)(H,90,110)(H,91,106)(H,92,103)(H,93,104)(H,94,112)(H,95,111)(H,96,107)(H,97,109)(H4,78,79,83)(H4,80,81,84)/t40-,41-,42-,43-,49-,50-,51-,52+,53-,54-,55-,56-,57-,58-,59-,60-,61-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LPUSOZUCMJWCPC-JMBCSMCCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01325, Melanocortin receptor 3
Protein ID: PT00914, Melanocortin receptor 4
Protein ID: PT01804, Melanocortin receptor 5
Protein ID: PT00911, Melanocyte-stimulating hormone receptor